PharmaOnco™ Human Immune Genome Editing Mouse Model, E-hIL3/hCSF2 (CAT#: ITS-1123-HM16)

Name: PharmaOnco™ Human Immune Genome Editing Mouse Model, E-hIL3/hCSF2
SKU: ITS-1123-HM16
Rating: 5 (1 reviews)

Datasheet

Description

This model improves human myeloid cell development in hu-HSC (CD34⁺ HSCs treatment mice) mice by overexpressing hIL3/hCSF2.

Applications

Human-specific infectious diseases; Antibody-based immune therapy; Human-specific vaccine development; Cell-based adoptiive immunity

Strain Name

NSG (E-hIL3/hCSF2)

Related Products

PharmaOnco™ Human Immune Genome Editing Mouse Model, hIL7 (CAT#: ITS-1123-HM18)
PharmaOnco™ Human Immune Genome Editing Mouse Model, hFcRN/hAlbumin (CAT#: ITS-1123-HM21)
PharmaOnco™ Human Immune Genome Editing Mouse Model, Db/Kd null (CAT#: ITS-1123-HM2)
PharmaOnco™ Human Immune Genome Editing Mouse Model, NOD/SCID/IL2Rg null (CAT#: ITS-1123-HM1)
PharmaOnco™ Human Immune Genome Editing Mouse Model, E-HSVtk (CAT#: ITS-1123-HM22)
PharmaOnco™ Human Immune Genome Editing Mouse Model, MHC null (CAT#: ITS-1123-HM3)
PharmaOnco™ Human Immune Genome Editing Mouse Model, hFLT3L (CAT#: ITS-1123-HM14)
PharmaOnco™ Human Immune Genome Editing Mouse Model, FcgRs null (CAT#: ITS-1123-HM9)

For Research Use Only | Not For Clinical Use

Online Inquiry

Overview